Chemically Induced Colitis-Associated Cancer Models in Rodents for Pharmacological Modulation: A Systematic Review
Animal models for colitis-associated colorectal cancer (CACC) represent an important tool to explore the mechanistic basis of cancer-related inflammation, providing important evidence that several inflammatory mediators play specific roles in the initiation and perpetuation of colitis and CACC. Alth...
Gespeichert in:
Veröffentlicht in: | Journal of clinical medicine 2022-05, Vol.11 (10), p.2739 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 10 |
container_start_page | 2739 |
container_title | Journal of clinical medicine |
container_volume | 11 |
creator | Modesto, Rita Estarreja, João Silva, Inês Rocha, João Pinto, Rui Mateus, Vanessa |
description | Animal models for colitis-associated colorectal cancer (CACC) represent an important tool to explore the mechanistic basis of cancer-related inflammation, providing important evidence that several inflammatory mediators play specific roles in the initiation and perpetuation of colitis and CACC. Although several original articles have been published describing the CACC model in rodents, there is no consensus about the induction method. This review aims to identify, summarize, compare, and discuss the chemical methods for the induction of CACC through the PRISMA methodology.
We searched MEDLINE via the Pubmed platform for studies published through March 2021, using a highly sensitive search expression. The inclusion criteria were only original articles, articles where a chemically-induced animal model of CACC is described, preclinical studies in vivo with rodents, and articles published in English.
Chemically inducible models typically begin with the administration of a carcinogenic compound (as azoxymethane (AOM) or 1,2-dimethylhydrazine (DMH)), and inflammation is caused by repeated cycles of colitis-inducing agents (such as 2,4,6-trinitrobenzenesulfonic acid (TNBS) or dextran sulfate sodium (DSS)). The strains mostly used are C57BL/6 and Balb/c with 5-6 weeks. To characterize the preclinical model, the parameters more used include body weight, stool consistency and morbidity, inflammatory biomarkers such as tumor necrosis factor (TNF)-α, interleukin (IL)-6 and IL-1β, angiogenesis markers such as proliferating cell nuclear antigen (PCNA), marker of proliferation Ki-67, and caspase 3, the presence of ulcers, thickness or hyperemia in the colon, and histological evaluation of inflammation.
The AOM administration seems to be important to the CACC induction method, since the carcinogenic effect is achieved with just one administration. DSS has been the more used inflammatory agent; however, the TNBS contribution should be more studied, since it allows a reliable, robust, and a highly reproducible animal model of intestinal inflammation. |
doi_str_mv | 10.3390/jcm11102739 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9146029</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2670189020</sourcerecordid><originalsourceid>FETCH-LOGICAL-c438t-1f49016c6f892d2f647ac8dba31801b88024074130b0b485df8972860ba5933e3</originalsourceid><addsrcrecordid>eNpdkd1LHDEUxYNUVOw--V4CfSmUsTfJbCbpQ2FZWhUUZdXnkMlk3CyZiU1mlP3vm8EP1uYl5yY_DudyEDohcMqYhB8b0xFCgFZM7qEjClVVABPs044-RLOUNpCPECUl1QE6ZHNOheDzIxSXa9s5o73f4ou-GY1t8DJ4N7hULFIKxulhetK9sRFfhcb6hF2PV1n1Q8JtiPhmrWOnTfDhYXKaqNHrwYX-J17g220abJdHg1f2ydnnz2i_1T7Z2et9jO7__L5bnheX12cXy8VlYUomhoK0pQTCDW-FpA1teVlpI5paMyKA1EIALaEqCYMa6lLMm8xVVHCo9VwyZtkx-vXi-zjWnW1Mzhu1V4_RdTpuVdBOffzp3Vo9hCclScmBymzw7dUghr-jTYPqXDLWe93bMCZFeUUol4SLjH79D92EMfZ5vYkCIiRQyNT3F8rEkFK07XsYAmqqU-3Umekvu_nf2bfy2D97oprq</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2670189020</pqid></control><display><type>article</type><title>Chemically Induced Colitis-Associated Cancer Models in Rodents for Pharmacological Modulation: A Systematic Review</title><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>PubMed Central Open Access</source><creator>Modesto, Rita ; Estarreja, João ; Silva, Inês ; Rocha, João ; Pinto, Rui ; Mateus, Vanessa</creator><creatorcontrib>Modesto, Rita ; Estarreja, João ; Silva, Inês ; Rocha, João ; Pinto, Rui ; Mateus, Vanessa</creatorcontrib><description>Animal models for colitis-associated colorectal cancer (CACC) represent an important tool to explore the mechanistic basis of cancer-related inflammation, providing important evidence that several inflammatory mediators play specific roles in the initiation and perpetuation of colitis and CACC. Although several original articles have been published describing the CACC model in rodents, there is no consensus about the induction method. This review aims to identify, summarize, compare, and discuss the chemical methods for the induction of CACC through the PRISMA methodology.
We searched MEDLINE via the Pubmed platform for studies published through March 2021, using a highly sensitive search expression. The inclusion criteria were only original articles, articles where a chemically-induced animal model of CACC is described, preclinical studies in vivo with rodents, and articles published in English.
Chemically inducible models typically begin with the administration of a carcinogenic compound (as azoxymethane (AOM) or 1,2-dimethylhydrazine (DMH)), and inflammation is caused by repeated cycles of colitis-inducing agents (such as 2,4,6-trinitrobenzenesulfonic acid (TNBS) or dextran sulfate sodium (DSS)). The strains mostly used are C57BL/6 and Balb/c with 5-6 weeks. To characterize the preclinical model, the parameters more used include body weight, stool consistency and morbidity, inflammatory biomarkers such as tumor necrosis factor (TNF)-α, interleukin (IL)-6 and IL-1β, angiogenesis markers such as proliferating cell nuclear antigen (PCNA), marker of proliferation Ki-67, and caspase 3, the presence of ulcers, thickness or hyperemia in the colon, and histological evaluation of inflammation.
The AOM administration seems to be important to the CACC induction method, since the carcinogenic effect is achieved with just one administration. DSS has been the more used inflammatory agent; however, the TNBS contribution should be more studied, since it allows a reliable, robust, and a highly reproducible animal model of intestinal inflammation.</description><identifier>ISSN: 2077-0383</identifier><identifier>EISSN: 2077-0383</identifier><identifier>DOI: 10.3390/jcm11102739</identifier><identifier>PMID: 35628865</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Blood ; Cancer therapies ; Cell cycle ; Chemotherapy ; Clinical medicine ; Colorectal cancer ; Inflammation ; Inflammatory bowel disease ; Medical prognosis ; Mortality ; Pathogenesis ; Review ; Systematic review ; Tumors</subject><ispartof>Journal of clinical medicine, 2022-05, Vol.11 (10), p.2739</ispartof><rights>2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2022 by the authors. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c438t-1f49016c6f892d2f647ac8dba31801b88024074130b0b485df8972860ba5933e3</citedby><cites>FETCH-LOGICAL-c438t-1f49016c6f892d2f647ac8dba31801b88024074130b0b485df8972860ba5933e3</cites><orcidid>0000-0003-2252-2769 ; 0000-0002-3204-3772 ; 0000-0001-7049-2512 ; 0000-0002-8283-3174 ; 0000-0002-0303-8085</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146029/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146029/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35628865$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Modesto, Rita</creatorcontrib><creatorcontrib>Estarreja, João</creatorcontrib><creatorcontrib>Silva, Inês</creatorcontrib><creatorcontrib>Rocha, João</creatorcontrib><creatorcontrib>Pinto, Rui</creatorcontrib><creatorcontrib>Mateus, Vanessa</creatorcontrib><title>Chemically Induced Colitis-Associated Cancer Models in Rodents for Pharmacological Modulation: A Systematic Review</title><title>Journal of clinical medicine</title><addtitle>J Clin Med</addtitle><description>Animal models for colitis-associated colorectal cancer (CACC) represent an important tool to explore the mechanistic basis of cancer-related inflammation, providing important evidence that several inflammatory mediators play specific roles in the initiation and perpetuation of colitis and CACC. Although several original articles have been published describing the CACC model in rodents, there is no consensus about the induction method. This review aims to identify, summarize, compare, and discuss the chemical methods for the induction of CACC through the PRISMA methodology.
We searched MEDLINE via the Pubmed platform for studies published through March 2021, using a highly sensitive search expression. The inclusion criteria were only original articles, articles where a chemically-induced animal model of CACC is described, preclinical studies in vivo with rodents, and articles published in English.
Chemically inducible models typically begin with the administration of a carcinogenic compound (as azoxymethane (AOM) or 1,2-dimethylhydrazine (DMH)), and inflammation is caused by repeated cycles of colitis-inducing agents (such as 2,4,6-trinitrobenzenesulfonic acid (TNBS) or dextran sulfate sodium (DSS)). The strains mostly used are C57BL/6 and Balb/c with 5-6 weeks. To characterize the preclinical model, the parameters more used include body weight, stool consistency and morbidity, inflammatory biomarkers such as tumor necrosis factor (TNF)-α, interleukin (IL)-6 and IL-1β, angiogenesis markers such as proliferating cell nuclear antigen (PCNA), marker of proliferation Ki-67, and caspase 3, the presence of ulcers, thickness or hyperemia in the colon, and histological evaluation of inflammation.
The AOM administration seems to be important to the CACC induction method, since the carcinogenic effect is achieved with just one administration. DSS has been the more used inflammatory agent; however, the TNBS contribution should be more studied, since it allows a reliable, robust, and a highly reproducible animal model of intestinal inflammation.</description><subject>Blood</subject><subject>Cancer therapies</subject><subject>Cell cycle</subject><subject>Chemotherapy</subject><subject>Clinical medicine</subject><subject>Colorectal cancer</subject><subject>Inflammation</subject><subject>Inflammatory bowel disease</subject><subject>Medical prognosis</subject><subject>Mortality</subject><subject>Pathogenesis</subject><subject>Review</subject><subject>Systematic review</subject><subject>Tumors</subject><issn>2077-0383</issn><issn>2077-0383</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNpdkd1LHDEUxYNUVOw--V4CfSmUsTfJbCbpQ2FZWhUUZdXnkMlk3CyZiU1mlP3vm8EP1uYl5yY_DudyEDohcMqYhB8b0xFCgFZM7qEjClVVABPs044-RLOUNpCPECUl1QE6ZHNOheDzIxSXa9s5o73f4ou-GY1t8DJ4N7hULFIKxulhetK9sRFfhcb6hF2PV1n1Q8JtiPhmrWOnTfDhYXKaqNHrwYX-J17g220abJdHg1f2ydnnz2i_1T7Z2et9jO7__L5bnheX12cXy8VlYUomhoK0pQTCDW-FpA1teVlpI5paMyKA1EIALaEqCYMa6lLMm8xVVHCo9VwyZtkx-vXi-zjWnW1Mzhu1V4_RdTpuVdBOffzp3Vo9hCclScmBymzw7dUghr-jTYPqXDLWe93bMCZFeUUol4SLjH79D92EMfZ5vYkCIiRQyNT3F8rEkFK07XsYAmqqU-3Umekvu_nf2bfy2D97oprq</recordid><startdate>20220512</startdate><enddate>20220512</enddate><creator>Modesto, Rita</creator><creator>Estarreja, João</creator><creator>Silva, Inês</creator><creator>Rocha, João</creator><creator>Pinto, Rui</creator><creator>Mateus, Vanessa</creator><general>MDPI AG</general><general>MDPI</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-2252-2769</orcidid><orcidid>https://orcid.org/0000-0002-3204-3772</orcidid><orcidid>https://orcid.org/0000-0001-7049-2512</orcidid><orcidid>https://orcid.org/0000-0002-8283-3174</orcidid><orcidid>https://orcid.org/0000-0002-0303-8085</orcidid></search><sort><creationdate>20220512</creationdate><title>Chemically Induced Colitis-Associated Cancer Models in Rodents for Pharmacological Modulation: A Systematic Review</title><author>Modesto, Rita ; Estarreja, João ; Silva, Inês ; Rocha, João ; Pinto, Rui ; Mateus, Vanessa</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c438t-1f49016c6f892d2f647ac8dba31801b88024074130b0b485df8972860ba5933e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Blood</topic><topic>Cancer therapies</topic><topic>Cell cycle</topic><topic>Chemotherapy</topic><topic>Clinical medicine</topic><topic>Colorectal cancer</topic><topic>Inflammation</topic><topic>Inflammatory bowel disease</topic><topic>Medical prognosis</topic><topic>Mortality</topic><topic>Pathogenesis</topic><topic>Review</topic><topic>Systematic review</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Modesto, Rita</creatorcontrib><creatorcontrib>Estarreja, João</creatorcontrib><creatorcontrib>Silva, Inês</creatorcontrib><creatorcontrib>Rocha, João</creatorcontrib><creatorcontrib>Pinto, Rui</creatorcontrib><creatorcontrib>Mateus, Vanessa</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of clinical medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Modesto, Rita</au><au>Estarreja, João</au><au>Silva, Inês</au><au>Rocha, João</au><au>Pinto, Rui</au><au>Mateus, Vanessa</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Chemically Induced Colitis-Associated Cancer Models in Rodents for Pharmacological Modulation: A Systematic Review</atitle><jtitle>Journal of clinical medicine</jtitle><addtitle>J Clin Med</addtitle><date>2022-05-12</date><risdate>2022</risdate><volume>11</volume><issue>10</issue><spage>2739</spage><pages>2739-</pages><issn>2077-0383</issn><eissn>2077-0383</eissn><abstract>Animal models for colitis-associated colorectal cancer (CACC) represent an important tool to explore the mechanistic basis of cancer-related inflammation, providing important evidence that several inflammatory mediators play specific roles in the initiation and perpetuation of colitis and CACC. Although several original articles have been published describing the CACC model in rodents, there is no consensus about the induction method. This review aims to identify, summarize, compare, and discuss the chemical methods for the induction of CACC through the PRISMA methodology.
We searched MEDLINE via the Pubmed platform for studies published through March 2021, using a highly sensitive search expression. The inclusion criteria were only original articles, articles where a chemically-induced animal model of CACC is described, preclinical studies in vivo with rodents, and articles published in English.
Chemically inducible models typically begin with the administration of a carcinogenic compound (as azoxymethane (AOM) or 1,2-dimethylhydrazine (DMH)), and inflammation is caused by repeated cycles of colitis-inducing agents (such as 2,4,6-trinitrobenzenesulfonic acid (TNBS) or dextran sulfate sodium (DSS)). The strains mostly used are C57BL/6 and Balb/c with 5-6 weeks. To characterize the preclinical model, the parameters more used include body weight, stool consistency and morbidity, inflammatory biomarkers such as tumor necrosis factor (TNF)-α, interleukin (IL)-6 and IL-1β, angiogenesis markers such as proliferating cell nuclear antigen (PCNA), marker of proliferation Ki-67, and caspase 3, the presence of ulcers, thickness or hyperemia in the colon, and histological evaluation of inflammation.
The AOM administration seems to be important to the CACC induction method, since the carcinogenic effect is achieved with just one administration. DSS has been the more used inflammatory agent; however, the TNBS contribution should be more studied, since it allows a reliable, robust, and a highly reproducible animal model of intestinal inflammation.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>35628865</pmid><doi>10.3390/jcm11102739</doi><orcidid>https://orcid.org/0000-0003-2252-2769</orcidid><orcidid>https://orcid.org/0000-0002-3204-3772</orcidid><orcidid>https://orcid.org/0000-0001-7049-2512</orcidid><orcidid>https://orcid.org/0000-0002-8283-3174</orcidid><orcidid>https://orcid.org/0000-0002-0303-8085</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2077-0383 |
ispartof | Journal of clinical medicine, 2022-05, Vol.11 (10), p.2739 |
issn | 2077-0383 2077-0383 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9146029 |
source | MDPI - Multidisciplinary Digital Publishing Institute; EZB-FREE-00999 freely available EZB journals; PubMed Central; PubMed Central Open Access |
subjects | Blood Cancer therapies Cell cycle Chemotherapy Clinical medicine Colorectal cancer Inflammation Inflammatory bowel disease Medical prognosis Mortality Pathogenesis Review Systematic review Tumors |
title | Chemically Induced Colitis-Associated Cancer Models in Rodents for Pharmacological Modulation: A Systematic Review |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T02%3A20%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Chemically%20Induced%20Colitis-Associated%20Cancer%20Models%20in%20Rodents%20for%20Pharmacological%20Modulation:%20A%20Systematic%20Review&rft.jtitle=Journal%20of%20clinical%20medicine&rft.au=Modesto,%20Rita&rft.date=2022-05-12&rft.volume=11&rft.issue=10&rft.spage=2739&rft.pages=2739-&rft.issn=2077-0383&rft.eissn=2077-0383&rft_id=info:doi/10.3390/jcm11102739&rft_dat=%3Cproquest_pubme%3E2670189020%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2670189020&rft_id=info:pmid/35628865&rfr_iscdi=true |